Efficacy and safety of anti-TNF agents in the Lombardy rheumatoid arthritis network (LORHEN)

Efficacy and safety of anti-TNF agents in the Lombardy rheumatoid arthritis network (LORHEN)

Clinical trials have shown that anti-tumour necrosis factor (TNF)-α drugs are effective in patients with rheumatoid arthritis (RA) refractory to disease- modifying antirheumatic drugs (DMARDs) (1-4). At about the same time as the European approval of the third anti-TNFα agent (adalimumab) for treati...

Full description

Bibliographic Details
Main Authors:	R. Caporali, M. Filippini, R. Gorla, E.G. Favalli, A. Marchesoni, M. Antivalle, P. Sarzi- Puttini, F. Bobbio-Pallavicini, C. Montecucco, F. Atzeni
Format:	Article
Language:	English
Published:	PAGEPress Publications 2011-09-01
Series:	Reumatismo
Online Access:	http://www.reumatismo.org/index.php/reuma/article/view/403

Similar Items

Effects of Anti-TNF Alpha Drugs on Disability in Patients with Rheumatoid Arthritis: Long-Term Real-Life Data from the Lorhen Registry
by: Matteo Filippini, et al.
Published: (2014-01-01)

Early rheumatoid arthritis
by: P. Sarzi-Puttini, et al.
Published: (2011-09-01)

Complementary medicine in rheumatoid arthritis
by: F. Atzeni, et al.
Published: (2011-09-01)

Do we have markers to define the cardiovascular risk in rheumatoid arthritis patients?
by: P. Sarzi-Puttini, et al.
Published: (2011-06-01)

Safety of rituximab in rheumatoid arthritis
by: F. Atzeni, et al.
Published: (2011-06-01)

TNFa inhibition in anti-Ro/SSA positive patients with rheumatoid arthritis: clinical and immunological effects
by: R. Cattaneo, et al.
Published: (2011-09-01)

Costs associated with rheumatoid arthritis in Italy: past, present, and future
by: Benucci M, et al.
Published: (2016-02-01)

Factors correlated with improvement of endothelial dysfunction during rituximab therapy in patients with rheumatoid arthritis
by: Benucci M, et al.
Published: (2013-03-01)

Cardiac involvement in rheumatoid arthritis
by: V. De Gennaro Colonna, et al.
Published: (2011-06-01)

Biomarkers of good EULAR response to the B cell depletion therapy in all seropositive rheumatoid arthritis patients: clues for the pathogenesis.
by: Gianfranco Ferraccioli, et al.
Published: (2012-01-01)

Pain in rheumatoid arthritis: a critical review
by: P. Sarzi-Puttini, et al.
Published: (2014-06-01)

The Clinical Value of Autoantibodies in Rheumatoid Arthritis
by: Serena Bugatti, et al.
Published: (2018-12-01)

Cost Effectiveness Analysis of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis. A Systematic Review Literature
by: Maurizio Benucci, et al.
Published: (2011-01-01)

Sarilumab: patient-reported outcomes in rheumatoid arthritis
by: Crotti C, et al.
Published: (2018-08-01)

Correlation of the score for subjective pain with physical disability, clinical and radiographic scores in recent onset rheumatoid arthritis
by: Turiel Maurizio, et al.
Published: (2002-07-01)

Accelerated subcutaneous nodulosis in patients with rheumatoid arthritis treated with tocilizumab: a case series
by: Rossella Talotta, et al.
Published: (2018-06-01)

Evaluation of Th9 lymphocytes in peripheral blood of rheumatoid arthritis patients and correlation with anti-tumor necrosis factor therapy: results from an in vitro pivotal study
by: R. Talotta, et al.
Published: (2016-09-01)

Outcome predictors in rheumatoid arthritis
by: C. Montecucco
Published: (2011-09-01)

Treatment Comparison in Rheumatoid Arthritis: Head-to-Head Trials and Innovative Study Designs
by: Ennio Giulio Favalli, et al.
Published: (2014-01-01)

Compressive cervical myelopathy due to massive periodontoid calcium pyrophosphate crystal deposition
by: F. Bobbio-Pallavicini, et al.
Published: (2001-12-01)

Cardiovascular involvement in psoriatic arthritis
by: V. De Gennaro Colonna, et al.
Published: (2011-11-01)

The Immunogenicity of Branded and Biosimilar Infliximab in Rheumatoid Arthritis According to Th9-Related Responses
by: Rossella Talotta, et al.
Published: (2017-10-01)

Spotlight on mavrilimumab for the treatment of rheumatoid arthritis: evidence to date
by: Crotti C, et al.
Published: (2017-01-01)

Profile of sarilumab and its potential in the treatment of rheumatoid arthritis
by: Raimondo MG, et al.
Published: (2017-05-01)

Early rheumatoid arthritis: a prospective study on how to induce the remission
by: S. Zingarelli, et al.
Published: (2011-09-01)

Tocilizumab in the treatment of rheumatoid arthritis: an evidence-based review and patient selection
by: Biggioggero M, et al.
Published: (2018-12-01)

Anti-TNFα agents in elderly patients with rheumatoid arthritis: a study of a group of 105 over sixty five years old patients
by: C. Biasini Rebaioli, et al.
Published: (2011-09-01)

B Cells in Rheumatoid Arthritis: From Pathogenic Players to Disease Biomarkers
by: Serena Bugatti, et al.
Published: (2014-01-01)

TNFα blockers and infectious risk in rheumatoid arthritis
by: S. Todesco, et al.
Published: (2011-06-01)

B-cell depletion and primary Sjögren’s syndrome: is there a role for rituximab?
by: P. Sarzi-Puttini, et al.
Published: (2011-06-01)

Switching between TNFα antagonists in rheumatoid arthritis: personal experience and review of the literature
by: M. Di Franco, et al.
Published: (2011-06-01)

The role of concomitant methotrexate dosage and maintenance over time in the therapy of rheumatoid arthritis patients treated with adalimumab or etanercept: retrospective analysis of a local registry
by: Favalli EG, et al.
Published: (2018-05-01)

TNF, SOLUBLE RECEPTORS AND AUTOANTIBODIES TO TNF OF PATIENTS WITH RHEUMATOID ARTHRITIS AND HEALTHY DONORS
by: E. A. Golikova, et al.
Published: (2012-05-01)

The Effect of TNF and Non-TNF-Targeted Biologics on Body Composition in Rheumatoid Arthritis
by: Gaelle Vial, et al.
Published: (2021-01-01)

TNF-α and TNF-β Gene Polymorphism in Saudi Rheumatoid Arthritis Patients
by: Hannan Al-Rayes, et al.
Published: (2011-06-01)

TNF-α and TNF-β Gene Polymorphism in Saudi Rheumatoid Arthritis Patients
by: Hannan Al-Rayes, et al.
Published: (2011-01-01)

Influence of TNF-α inhibition on oxidative stress of rheumatoid arthritis patients
by: F. Cacciapaglia, et al.
Published: (2016-02-01)

Cost Effectiveness of TNF-α Inhibitors in Rheumatoid Arthritis
by: Cynthia Said, et al.
Published: (2013-01-01)

THE METABOLIC EFFECTS OF TNF INHIBITORS IN RHEUMATOID ARTHRITIS PATIENTS
by: Alexandra Jitaru, et al.
Published: (2019-12-01)

Tofacitinib: Real-World Data and Treatment Persistence in Rheumatoid Arthritis
by: Bertoldi I, et al.
Published: (2021-07-01)

Cannot write session to /tmp/vufind_sessions/sess_gtar17qo636oblqeuvk5t6quhh